Anticancer Drugs Market Report

China Anticancer Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Sep 14, 2023
  • PAGES：173
  • REPORT CODE：GMM1797332
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Antineoplastic drugs, also known as anticancer drugs, anti-malignant drugs, refer to drugs for the treatment of malignant tumors.

    This report elaborates on the current development of the Anticancer Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Pfizer Inc

    • AstraZeneca

    • Novartis AG

    • Eli Lilly and Company

    • Takeda Pharmaceutical Company Limited

    • Bayer AG

    • Amgen Inc

    By Type:

    • Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)

    • Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)

    • Hormonal Drugs

    By Application:

    • Lung Cancer

    • Breast Cancer

    • Leukemia

    • Colorectal Cancer

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Anticancer Drugs Market Overview 2018-2029

    • 1.1 China Anticancer Drugs Industry Development Overview

    • 1.2 China Anticancer Drugs Industry Development History

    • 1.3 China Anticancer Drugs Industry Market Size (2018-2029)

    • 1.4 China Anticancer Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Anticancer Drugs Production Volume, Production Value and Growth Rate of Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors) (2018-2029)

      • 1.4.2 China Anticancer Drugs Production Volume, Production Value and Growth Rate of Cytotoxic Drugs (Alkylating Agents, and Antimetabolites) (2018-2029)

      • 1.4.3 China Anticancer Drugs Production Volume, Production Value and Growth Rate of Hormonal Drugs (2018-2029)

    • 1.5 China Anticancer Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Anticancer Drugs Sales Volume, Sales Value and Growth Rate of Lung Cancer (2018-2029)

      • 1.5.2 China Anticancer Drugs Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

      • 1.5.3 China Anticancer Drugs Sales Volume, Sales Value and Growth Rate of Leukemia (2018-2029)

      • 1.5.4 China Anticancer Drugs Sales Volume, Sales Value and Growth Rate of Colorectal Cancer (2018-2029)

    • 1.6 China Anticancer Drugs Market Analysis by Region

      • 1.6.1 North China Anticancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Anticancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Anticancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Anticancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Anticancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Anticancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Anticancer Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Anticancer Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Anticancer Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Anticancer Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Anticancer Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Anticancer Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Anticancer Drugs Industry Development

    Chapter 3 Anticancer DrugsIndustry Chain Analysis

    • 3.1 Anticancer Drugs Industry Chain

    • 3.2 Anticancer Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Anticancer Drugs Market

    • 3.3 Anticancer Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Anticancer Drugs Market

    Chapter 4 China Anticancer Drugs Market, by Type

    • 4.1 China Anticancer Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Anticancer Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Anticancer Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Anticancer Drugs Production Volume and Growth Rate of Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)

      • 4.5.2 China Anticancer Drugs Production Volume and Growth Rate of Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)

      • 4.5.3 China Anticancer Drugs Production Volume and Growth Rate of Hormonal Drugs

    Chapter 5 China Anticancer Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Anticancer Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Anticancer Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Anticancer Drugs Market Size and Growth Rate of Lung Cancer

      • 5.5.2 China Anticancer Drugs Market Size and Growth Rate of Breast Cancer

      • 5.5.3 China Anticancer Drugs Market Size and Growth Rate of Leukemia

      • 5.5.4 China Anticancer Drugs Market Size and Growth Rate of Colorectal Cancer

    Chapter 6 China Anticancer Drugs Market, by Region

    • 6.1 China Anticancer Drugs Production Volume and Production Value, by Region

    • 6.2 China Anticancer Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Anticancer Drugs Market Analysis

    • 7.1 North China Anticancer Drugs Market, by Type

    • 7.2 North China Anticancer Drugs Market, by Application

    Chapter 8 Central China Anticancer Drugs Market Analysis

    • 8.1 Central China Anticancer Drugs Market, by Type

    • 8.2 Central China Anticancer Drugs Market, by Application

    Chapter 9 South China Anticancer Drugs Market Analysis

    • 9.1 South China Anticancer Drugs Market, by Type

    • 9.2 South China Anticancer Drugs Market, by Application

    Chapter 10 East China Anticancer Drugs Market Analysis

    • 10.1 East China Anticancer Drugs Market, by Type

    • 10.2 East China Anticancer Drugs Market, by Application

    Chapter 11 Northeast China Anticancer Drugs Market Analysis

    • 11.1 Northeast China Anticancer Drugs Market, by Type

    • 11.2 Northeast China Anticancer Drugs Market, by Application

    Chapter 12 Southwest China Anticancer Drugs Market Analysis

    • 12.1 Southwest China Anticancer Drugs Market, by Type

    • 12.2 Southwest China Anticancer Drugs Market, by Application

    Chapter 13 Northwest China Anticancer Drugs Market Analysis

    • 13.1 Northwest China Anticancer Drugs Market, by Type

    • 13.2 Northwest China Anticancer Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Pfizer Inc

        • 14.1.1 Pfizer Inc Company Profile

        • 14.1.2 Pfizer Inc Anticancer Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 AstraZeneca

        • 14.2.1 AstraZeneca Company Profile

        • 14.2.2 AstraZeneca Anticancer Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Novartis AG

        • 14.3.1 Novartis AG Company Profile

        • 14.3.2 Novartis AG Anticancer Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Eli Lilly and Company

        • 14.4.1 Eli Lilly and Company Company Profile

        • 14.4.2 Eli Lilly and Company Anticancer Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Takeda Pharmaceutical Company Limited

        • 14.5.1 Takeda Pharmaceutical Company Limited Company Profile

        • 14.5.2 Takeda Pharmaceutical Company Limited Anticancer Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Bayer AG

        • 14.6.1 Bayer AG Company Profile

        • 14.6.2 Bayer AG Anticancer Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Amgen Inc

        • 14.7.1 Amgen Inc Company Profile

        • 14.7.2 Amgen Inc Anticancer Drugs Market Performance

        • 14.7.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Anticancer Drugs Industry Research Conclusions

    • 15.2 Anticancer Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Anticancer Drugs Industry Market Size (2018-2029)

    • Figure China Anticancer Drugs Production Volume, Production Value and Growth Rate of Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors) (2018-2029)

    • Figure China Anticancer Drugs Production Volume, Production Value and Growth Rate of Cytotoxic Drugs (Alkylating Agents, and Antimetabolites) (2018-2029)

    • Figure China Anticancer Drugs Production Volume, Production Value and Growth Rate of Hormonal Drugs (2018-2029)

    • Figure China Anticancer Drugs Sales Volume, Sales Value and Growth Rate of Lung Cancer (2018-2029)

    • Figure China Anticancer Drugs Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

    • Figure China Anticancer Drugs Sales Volume, Sales Value and Growth Rate of Leukemia (2018-2029)

    • Figure China Anticancer Drugs Sales Volume, Sales Value and Growth Rate of Colorectal Cancer (2018-2029)

    • Figure North China Anticancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Anticancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Anticancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Anticancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Anticancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Anticancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Anticancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure Anticancer Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Anticancer Drugs Market Share by Type in 2018

    • Figure China Anticancer Drugs Market Share by Type in 2023

    • Figure China Anticancer Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Anticancer Drugs Production Volume and Growth Rate of Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors) (2018-2023)

    • Figure China Anticancer Drugs Production Volume and Growth Rate of Cytotoxic Drugs (Alkylating Agents, and Antimetabolites) (2018-2023)

    • Figure China Anticancer Drugs Production Volume and Growth Rate of Hormonal Drugs (2018-2023)

    • Figure China Anticancer Drugs Market Share by Application in 2018

    • Figure China Anticancer Drugs Market Share by Application in 2023

    • Figure China Anticancer Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Anticancer Drugs Market Size and Growth Rate of Lung Cancer (2018-2023)

    • Figure China Anticancer Drugs Market Size and Growth Rate of Breast Cancer (2018-2023)

    • Figure China Anticancer Drugs Market Size and Growth Rate of Leukemia (2018-2023)

    • Figure China Anticancer Drugs Market Size and Growth Rate of Colorectal Cancer (2018-2023)

    • Table China Anticancer Drugs Production Volume by Region (2018-2023)

    • Table China Anticancer Drugs Production Volume Share by Region (2018-2023)

    • Figure China Anticancer Drugs Production Volume Share by Region (2018-2023)

    • Table China Anticancer Drugs Production Value by Region (2018-2023)

    • Table China Anticancer Drugs Production Value Share by Region (2018-2023)

    • Figure China Anticancer Drugs Production Value Share by Region (2018-2023)

    • Table China Anticancer Drugs Sales Volume by Region (2018-2023)

    • Table China Anticancer Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Anticancer Drugs Sales Volume Share by Region (2018-2023)

    • Table China Anticancer Drugs Sales Value by Region (2018-2023)

    • Table China Anticancer Drugs Sales Value Share by Region (2018-2023)

    • Figure China Anticancer Drugs Sales Value Share by Region (2018-2023)

    • Table North China Anticancer Drugs Production Volume by Type (2018-2023)

    • Table North China Anticancer Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Anticancer Drugs Production Volume Share by Type (2018-2023)

    • Table North China Anticancer Drugs Sales Volume by Application (2018-2023)

    • Table North China Anticancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Anticancer Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Anticancer Drugs Production Volume by Type (2018-2023)

    • Table Central China Anticancer Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Anticancer Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Anticancer Drugs Sales Volume by Application (2018-2023)

    • Table Central China Anticancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Anticancer Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Anticancer Drugs Production Volume by Type (2018-2023)

    • Table South China Anticancer Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Anticancer Drugs Production Volume Share by Type (2018-2023)

    • Table South China Anticancer Drugs Sales Volume by Application (2018-2023)

    • Table South China Anticancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Anticancer Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Anticancer Drugs Production Volume by Type (2018-2023)

    • Table East China Anticancer Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Anticancer Drugs Production Volume Share by Type (2018-2023)

    • Table East China Anticancer Drugs Sales Volume by Application (2018-2023)

    • Table East China Anticancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Anticancer Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Anticancer Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Anticancer Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Anticancer Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Anticancer Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Anticancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Anticancer Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Anticancer Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Anticancer Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Anticancer Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Anticancer Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Anticancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Anticancer Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Anticancer Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Anticancer Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Anticancer Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Anticancer Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Anticancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Anticancer Drugs Sales Volume Share by Application (2018-2023)

    • Table Pfizer Inc Company Profile

    • Table Pfizer Inc Anticancer Drugs Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Anticancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Anticancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly and Company Company Profile

    • Table Eli Lilly and Company Anticancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Takeda Pharmaceutical Company Limited Company Profile

    • Table Takeda Pharmaceutical Company Limited Anticancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Bayer AG Company Profile

    • Table Bayer AG Anticancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Amgen Inc Company Profile

    • Table Amgen Inc Anticancer Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US